Evidence map›Paper›PMID 35899312›Full record

ArticleStatistical methods in medical research2022

Analysis of hospital readmissions with competing risks.

Wenbo Wu, Kevin He, Xu Shi, Douglas E Schaubel, John D Kalbfleisch

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Readmission Requires Survival and Access: Reframing Global Quality Metrics in Cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenbo WuDepartment of Biostatistics and Kidney Epidemiology and Cost Center, 51329University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID 0000-0002-7642-9773
Kevin HeDepartment of Biostatistics and Kidney Epidemiology and Cost Center, 51329University of Michigan School of Public Health, Ann Arbor, MI, USA.
Xu ShiDepartment of Biostatistics and Kidney Epidemiology and Cost Center, 51329University of Michigan School of Public Health, Ann Arbor, MI, USA.
Douglas E SchaubelDepartment of Biostatistics, Epidemiology and Informatics, 14640University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0002-9792-4474
John D KalbfleischDepartment of Biostatistics and Kidney Epidemiology and Cost Center, 51329University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID 0000-0001-9198-9667

Funding

Survival Analysis Methods for Organ Failure DataR01DK070869 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DOUGLAS EARL SCHAUBEL · 2005 to 2026
$4.7M
Improve Statistical Methods for Profiling of Healthcare ProvidersR01DK129539 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Zhi Kevin He · 2022 to 2026
$1.6M
NIDDK NIH HHS R01 DK070869NIDDK NIH HHS R01 DK129539
6 · The paper itself

Abstract

The 30-day hospital readmission rate has been used in provider profiling for evaluating inter-provider care coordination, medical cost effectiveness, and patient quality of life. Current profiling analyzes use logistic regression to model 30-day readmission as a binary outcome, but one disadvantage of this approach is that this outcome is strongly affected by competing risks (e.g., death). Thus, one, perhaps unintended, consequence is that if two facilities have the same rates of readmission, the one with the higher rate of competing risks will have the lower 30-day readmission rate. We propose a discrete time competing risk model wherein the cause-specific readmission hazard is used to assess provider-level effects. This approach takes account of the timing of events and focuses on the readmission rates which are of primary interest. The quality measure, then is a standardized readmission ratio, akin to a standardized mortality ratio. This measure is not systematically affected by the rate of competing risks. To facilitate the estimation and inference of a large number of provider effects, we develop an efficient Blockwise Inversion Newton algorithm, and a stabilized robust score test that overcomes the conservative nature of the classical robust score test. An application to dialysis patients demonstrates improved profiling, model fitting, and outlier detection over existing methods.

Indexed as

Patient ReadmissionQuality of LifeHumansLogistic ModelsRenal DialysisCause-specific hazarddiscrete survival modelprovider profilingrobust inferencestandardization

Identifiers

PMID35899312
PMCPMC9931495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.